연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1351. Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer.
Kim S1, Kim TM, Kim DW, Go H, Keam B, Lee SH, Ku JL, Chung DH, Heo DS.
J Thorac Oncol. 2013 Apr;8(4):415-22. doi: 10.1097/JTO.0b013e318283dcc0.
Link
1350. Clinical characteristics of pediatric thalassemia in Korea: a single institute experience.
Hong CR1, Kang HJ, Lee JW, Kim H, Kim NH, Park KD, Park JD, Seong MW, Park SS, Shin HY, Ahn HS.
J Korean Med Sci. 2013 Nov;28(11):1645-9. doi: 10.3346/jkms.2013.28.11.1645. Epub 2013 Oct 31.
Link
1349. Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.
Kim H1, Kang HJ, Lee JW, Park JD, Park KD, Shin HY, Ahn HS.
Childs Nerv Syst. 2013 Oct;29(10):1851-8. doi: 10.1007/s00381-013-2163-z. Epub 2013 Jun 9.
Link
1348. Pharmacogenetic study of deferasirox, an iron chelating agent.
Lee JW1, Kang HJ, Choi JY, Kim NH, Jang MK, Yeo CW, Lee SS, Kim H, Park JD, Park KD, Shin HY, Shin JG, Ahn HS.
PLoS One. 2013 May 30;8(5):e64114. doi: 10.1371/journal.pone.0064114. Print 2013.
Link
1347. Peri-engraftment syndrome in allogeneic hematopoietic SCT.
Hong KT1, Kang HJ, Kim NH, Kim MS, Lee JW, Kim H, Park KD, Shin HY, Ahn HS.
Bone Marrow Transplant. 2013 Apr;48(4):523-8. doi: 10.1038/bmt.2012.171. Epub 2012 Sep 24.
Link
1346. Differential clinicopathologic features in microsatellite-unstable gastric cancers with and without MLH1 methylation.
Kim KJ, Lee TH, Cho NY, Yang HK, Kim WH, Kang GH.
Hum Pathol. 2013 Jun;44(6):1055-64. doi: 10.1016/j.humpath.2012.09.009. Epub 2012 Dec 23.
Link
1345. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
Bae JM, Kim JH, Kang GH.
Histol Histopathol. 2013 May;28(5):585-95. Epub 2013 Jan 23.
Link
1344. Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status.
Kim JH, Rhee YY, Bae JM, Kwon HJ, Cho NY, Kim MJ, Kang GH.
Mod Pathol. 2013 Jul;26(7):1013-22. doi: 10.1038/modpathol.2012.241. Epub 2013 Feb 1.
Link
1343. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH, Park SY, Kang GH.
Am J Pathol. 2013 Apr;182(4):1275-85. doi: 10.1016/j.ajpath.2013.01.004. Epub 2013 Feb 10.
Link
1342. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.
Bae JM, Kim JH, Cho NY, Kim TY, Kang GH.
Br J Cancer. 2013 Aug 20;109(4):1004-12. doi: 10.1038/bjc.2013.430. Epub 2013 Jul 30.
Link